Advances in Cancers and Tumor Targeted Immunotherapy
A special issue of Applied Sciences (ISSN 2076-3417). This special issue belongs to the section "Applied Biosciences and Bioengineering".
Deadline for manuscript submissions: 30 May 2026 | Viewed by 8
Special Issue Editors
Interests: biomedical science; bioscience; structural bioinformatics and structural biology; DNA repair; cancer biology; molecular genetics; cell signaling; genome stability; ovarian cancer; cancer stem cells
Interests: iPSCs; organoids; CAR-T; CAR-NK; autophagy; tumoroids; CRISPR Cas
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Cancer is a disease of abnormal gene expression, gene mutations, or dramatic changes in gene regulation. Combination therapy and immunotherapy, offers a path to enhanced outcomes, exemplified by groundbreaking approaches like CAR T-cell therapy. However, the field faces significant challenges, including tumor heterogeneity, variable patient responses, and the development of treatment resistance and disease recurrence. A primary driver of this resistance is the resilience of cancer stem cells (CSCs), which are often resistant to traditional treatments and contribute to disease relapse. Moreover, the intricate interplay between the tumor microenvironment and immune cells can lead to chemoresistance, undermining both chemotherapy and immunotherapy. Overcoming hurdles in cancer treatment and optimizing personalized therapies requires a critical comprehension of the tumor’s intricate nature.
We welcome Review and Research Articles exploring advances in Cancer research and treatment. Submissions should prioritize innovative and non-invasive strategies, such as studies on Cancer Stem Cells, the development of CAR-T therapies, CAR NK therapy, computational modeling, and the application of Artificial Intelligence (AI) methods for cancer diagnosis and therapy.
Dr. Kaushlendra Tripathi
Dr. Kulbhushan Sharma
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Applied Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cancer immunotherapy and DNA damage
- cancer stem cell and chemoresistance
- organoid and spheroid
- combination drug therapy
- cancer therapy
- drug delivery systems
- cocultures
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
